A proactive medical necessity review program reduces revenue loss associated with outpatient medical benefit drugs
Purpose: A common denial trend that occurs with "outpatient medical benefit drugs"(ie, medications covered by a medical benefit plan and administered in an outpatient visit) is payers not requiring or permitting prior authorization (PA) proactively, yet denying the drug after administratio...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Oxford University Press
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |